Xtrava

Xtrava Health, founded in Silicon Valley, is dedicated to developing, manufacturing, and commercializing simple-to-use, accurate, and affordable diagnostic products for both health professionals and at-home use. The company focuses on leveraging next-generation technology and strategic global partnerships to enhance healthcare diagnostics. Their flagship product, the SPERA™ COVID-19 Antigen Test, is FDA EUA-authorized and designed to provide accurate, cost-effective, and high-volume testing solutions for various settings, including health clinics, drive-up testing centers, and event venues.

Notable figures affiliated with Xtrava Health include key industry experts and strategic investors who support the company's mission of improving diagnostic accessibility and accuracy. Among their significant achievements is the rapid development and authorization of the SPERA™ COVID-19 Antigen Test, which has had a substantial impact on increasing the availability of reliable COVID-19 testing. Xtrava Health continues to make strides in the diagnostics industry, contributing to safer communities and more efficient healthcare responses.